|1.||Scorza, Raffaella: 3 articles (05/2010 - 06/2002)|
|2.||Lenna, Stefania: 2 articles (05/2010 - 03/2007)|
|3.||Walker, Bruce D: 2 articles (07/2007 - 10/2003)|
|4.||Beretta, Lorenzo: 2 articles (03/2007 - 06/2002)|
|5.||Antonioli, Rita: 2 articles (03/2007 - 06/2002)|
|6.||Scorza, R: 2 articles (09/2006 - 09/2000)|
|7.||Garcia-Tellez, Thalía: 1 article (07/2014)|
|8.||Reyes-Teran, Gustavo: 1 article (07/2014)|
|9.||Valenzuela-Ponce, Humberto: 1 article (07/2014)|
|10.||Avila-Rios, Santiago: 1 article (07/2014)|
08/01/1983 - "The frequency of HLA-Bw35 in a group of 60 non-uremic patients with biopsy-proven glomerulonephritis and without malignant hypertension was also studied and found equal to the group of healthy blood donors. "
01/10/1981 - "The analysis of HLA-Bw35 in 23 patients with IgA mesangial glomerulonephritis gave positive results in 30% of them, while the control group had a positivity of 15% (p non significant with the X2 test). "
08/01/1983 - "There was no overrepresentation of IgA nephritis among the HLA-Bw35 positive patients with glomerulonephritis, but advanced vascular lesions were more common among these than among patients with other HLA antigens."
|2.||Pemphigus (Pemphigus Vulgaris)
04/01/2004 - "Studies showed that the associated HLA haplotype in Jewish pemphigus vulgaris (PV) patients is HLA-B38, DRB1*0402, and DQB1*0302; or HLA-B35, DRB1*0402, and DQB1*0302. "
06/01/1991 - "Previous studies demonstrated that HLA-DR4 was markedly increased among Ashkenazi Jewish patients with pemphigus vulgaris (PV), almost entirely as the common Jewish extended haplotype [HLA-B38, SC21, DR4, DQw8] or as the haplotype HLA-B35, SC31, DR4, DQw8, and that HLA-DR4, DQw8 was distributed among patients in a manner consistent with dominant expression of a class II (D-region or D-region-linked) susceptibility gene. "
02/01/2002 - "We postulate that HLA-B35, B44, CW4, DR4, DR14, DQ4 and DQ8 antigens may be responsible for susceptibility to pemphigus while HLA-DR11, DQ7 and DQ2 antigens may have a protective role in the Turkish population."
|3.||Acquired Immunodeficiency Syndrome (AIDS)
01/01/2012 - "The presence of HLA-B35 may simultaneously predispose to progression to AIDS and TRC."
05/01/2009 - "HLA-B35 has been consistently reported as a risk factor in the progression to AIDS. "
04/01/1993 - "Individuals with HLA-B35 showed a significantly faster rate of progression to AIDS over the follow-up period than HLA-B35-negative individuals (hazard ratio, 2.72; P = 0.037). "
04/01/1993 - "Progression to AIDS in French haemophiliacs: association with HLA-B35."
01/01/1992 - "In the case-control study, there was a significantly higher frequency of HLA-B35 among intravenous drug users, but not homosexuals, who developed illnesses meeting the case definition for AIDS compared with asymptomatic HIV-positive controls, regardless of ethnic status. "
|4.||Pulmonary Hypertension (Ayerza Syndrome)
05/01/2010 - "This study suggests that HLA-B35 could contribute to EC dysfunction via ER stress-mediated induction of ET-1 in patients with pulmonary hypertension."
05/01/2010 - "The presence of the HLA-B35 allele has emerged as an important risk factor for the development of isolated pulmonary hypertension in patients with scleroderma, however the mechanisms underlying this association have not been fully elucidated. "
09/01/2006 - "HLA-B35 is associated with an increased risk for developing isolated pulmonary hypertension (iPHT) in systemic sclerosis, but the mechanisms underlying this association have not been fully elucidated yet. "
09/01/2006 - "HLA-B35 upregulates the production of endothelin-1 in HLA-transfected cells: a possible pathogenetic role in pulmonary hypertension."
09/01/2000 - "Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35."
|5.||Venous Thrombosis (Deep-Vein Thrombosis)
|1.||Immunoglobulin A (IgA)
|4.||HLA-B Antigens (HLA-B)
|5.||HLA-DR4 Antigen (HLA DR4 Antigen)
|8.||HLA-A2 Antigen (HLA A2 Antigen)
|9.||HLA-B8 Antigen (HLA B8 Antigen)
|10.||HLA-A1 Antigen (HLA A1 Antigen)
|2.||Homologous Transplantation (Allograft)